extensive stage sclc Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (3)

Phase 1 (1)
Phase 2 (1)
Phase 3 (1)

Interventional (3)

Hoffmann-La Roche (2)
AIO-Studien-gGmbH (1)

No (3)

No (3)

Adult (18+) (3)

I am/have/had

I am/have/hadcancer chemotherapy

I am/have/hadsolid neoplasm

I am/have/hadaptt

I am/have/hadmetastasis

I am/have/hadsolid tumour

I am/have/hadcerebrovascular disease

I am/have/hadchemotherapy regimen

I am/have/hadcancer therapy

I am/have/hadbrain metastases

I am/have/hadsteroid therapy

I am/have/hadHIV Infection

I am/have/hadcns metastases

I am/have/hadchemoradiotherapy

I am/have/hadsmall cell lung cancer

I am/have/hadmaintenance therapy

I am/have/hadlung cancer

I am/have/hadneutrophil count

I am/have/hadbrain metastasis

I am/have/hadneuroendocrine tumor

I am/have/hadsolid organ transplant

added new label for I am/have/had

I am looking for

I am looking forvenetoclax

I am looking foripilimumab

I am looking forgranulocyte colony stimulating factor

I am looking forcorticosteroid therapy

I am looking fortiragolumab

I am looking forgcsf

I am looking forimmunosuppressive

I am looking foretoposide

I am looking forcarboplatin

I am looking forimmunosuppressant

I am looking foratezolizumab

I am looking forsteroid therapy

I am looking forcolony stimulating factor

I am looking forg-csf

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer

This study will evaluate the efficacy of tiragolumab plus atezolizumab and carboplatin and etoposide (CE) compared with placebo plus atezolizumab and CE in participants with chemotherapy-naive extensive-stage small cell lung cancer (ES-SCLC). Eligible participants will be randomized in a 1:1 ratio to receive one of the following treatment regimens during …

solid neoplasm

tiragolumab

small cell lung cancer

extensive stage sclc

measurable disease

0 views
19 Feb, 2024

A Study Evaluating The Safety Tolerability Pharmacokinetics And Efficacy Of Venetoclax In Combination With Atezolizumab Carboplatin And Etoposide In Participants With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC).

A study consisting of a dose-escalation phase and a dose-expansion phase to evaluate the safety, tolerability, pharmacokinetics, and efficacy of venetoclax in combination with atezolizumab, carboplatin, and etoposide.

cancer chemotherapy

cancer treatment

metastasis

gcsf

extensive stage sclc

0 views
19 Feb, 2024

Patients With ES-SCLC and ECOG PS=2 Receiving Atezolizumab-Carboplatin-Etoposide

Small cell lung cancer (SCLC) is a rapidly proliferating, neuroendocrine tumor that accounts for about 15% of all lung cancers. Most patients have metastases at primary diagnosis involving sites like bone, adrenal glands, liver and brain. Compared with non-small-cell lung cancer (NSCLC) SCLC has a unique natural history with a …

aptt

metastasis

immunosuppressive

cerebrovascular disease

brain metastases

0 views
19 Feb, 2024